Antiplatelet therapy forms the cornerstone of pharmacological management following percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). For decades, dual antiplatelet therapy (DAPT) — conventionally comprising aspirin combined with a P2Y12 rece...
Open access
Research Article10.9734/ajcr/2026/v9i1367
Introduction: Heart failure with reduced ejection fraction (HFrEF), defined as LVEF ≤ 40%, is a major public health problem due to its high morbidity and mortality, affecting approximately 64.3 million individuals worldwide, of whom nearly 50% present with reduced ejection fracti...
Open access
Research Article10.9734/ajcr/2026/v9i1368
Background: The rare cardiac involvement of neuroendocrine tumors (NETs), uncommon neoplasms with neuroendocrine differentiation that typically arise in the gastroenteropancreatic and pulmonary systems but may present with constitutional symptoms, arrhythmias, thromboembolic even...
Open access
Research Article10.9734/ajcr/2026/v9i1369
Background: Lipoprotein A is a genetically determined low-density lipoprotein like particle bound covalently to apolipoprotein. It is increasingly recognized as a highly atherogenic and prothrombotic molecule, contributing to the development and progression of atherosclerotic car...
Open access
Research Article10.9734/ajcr/2026/v9i1365
Background: Short-term outcomes in HFrEF, including in-hospital mortality and 30-day rehospitalization, reflect the quality of acute care and the adequacy of discharge management. Data from North African settings remain scarce. Aim: The study aims to evaluate in-hospital outcomes...
Open access
Research Article10.9734/ajcr/2026/v9i1366
Human immunodeficiency virus (HIV) infection remains a significant global health challenge. While the introduction of highly active antiretroviral therapy (HAART) has greatly improved survival and quality of life, it has also been associated with metabolic complications, includin...
Open access
Research Article10.9734/ajcr/2026/v9i1364
Background: Drug-eluting balloons (DCBs) have emerged as an important alternative to stent-based strategies in percutaneous coronary intervention (PCI), particularly in clinical scenarios where permanent metallic implantation may be undesirable. While randomized trials have demon...
Open access
Research Article10.9734/ajcr/2026/v9i1363
Background: Cardiovascular diseases remain the leading cause of death globally, with hypertension and elevated total cholesterol as key modifiable risk factors. Their coexistence markedly increases cardiovascular risk. In Nigeria, both conditions are common among hypertensive pat...
Open access
Research Article10.9734/ajcr/2026/v9i1362
D. Bennani, A. El Bouazizi, L. Afendi, F. Essadqi, M. HABOUB, A. DRIGHIL, K. Gourram, Y. Sakhy, H. Tabakh, A. Siwane, N. Touil & O. Kacimi·Asian Journal of Cardiology Research·2026
We report the case of an acute embolic-appearing ischemic stroke that led to the diagnosis of a complex aortic pathology combining an ascending aortic aneurysm, defined as a permanent pathological dilation of the proximal aorta conferring a major risk of dissection or rupture, an...
Open access
Research Article10.9734/ajcr/2026/v9i1361
Aim: This case study aims to emphasize the importance of maintaining a broad differential diagnosis when evaluating young hypertensive patients with retinal manifestations. The case emphasizes the need for early identification of secondary causes of hypertension such as polycythe...
Open access
Research Article10.9734/ajcr/2026/v9i1360